# Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma

> **NCT07482774** · — · NOT_YET_RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 12 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **OTHER:** Biological: Tumor Tissue and Blood Sample Collection

## Key facts

- **NCT ID:** NCT07482774
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07482774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07482774, "Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07482774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*